Pekkinen J et al. |
Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach. |
2013 |
Mol Nutr Food Res |
pmid:23868375
|
Riccioni C et al. |
Rehabilitative treatment in peripheral artery disease: protocol application and follow-up. |
2010 |
Minerva Cardioangiol |
pmid:20948502
|
Cotter MA et al. |
Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes. |
1995 |
Metab. Clin. Exp. |
pmid:7666797
|
Brass EP and Beyerinck RA |
Interactions of propionate and carnitine metabolism in isolated rat hepatocytes. |
1987 |
Metab. Clin. Exp. |
pmid:3110541
|
Ferrari R et al. |
Metabolic modulation and optimization of energy consumption in heart failure. |
2003 |
Med. Clin. North Am. |
pmid:12693736
|
Barker GA et al. |
Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease. |
2001 |
Med Sci Sports Exerc |
pmid:11528327
|
Odiet JA et al. |
Carnitine palmitoyl transferase-I activity in the aging mouse heart. |
1995 |
Mech. Ageing Dev. |
pmid:7616763
|
Hozyasz KK et al. |
Whole blood propionylcarnitine in newborns with orofacial cleft. |
2011 |
Matern Child Nutr |
pmid:21470367
|
Gómez-Amores L et al. |
Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats. |
2006 |
Life Sci. |
pmid:16263137
|
Bueno R et al. |
L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products. |
2005 |
Life Sci. |
pmid:15958269
|
Mister M et al. |
Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. |
2002 |
Kidney Int. |
pmid:11849462
|
Azzollini N et al. |
Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation. |
2008 |
Kidney Int. |
pmid:19008910
|
Signorelli SS et al. |
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease. |
2006 |
Kidney Blood Press. Res. |
pmid:16809937
|
Sarafoglou K et al. |
Expanded newborn screening for detection of vitamin B12 deficiency. |
2011 |
JAMA |
pmid:21427371
|
Cipolla MJ et al. |
Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism. |
1999 |
J. Vasc. Surg. |
pmid:10359944
|
Loffredo L et al. |
Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. |
2006 |
J. Vasc. Surg. |
pmid:16950429
|
Alvarez de Sotomayor M et al. |
Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. |
2007 |
J. Vasc. Res. |
pmid:17483601
|
Safarinejad MR et al. |
Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. |
2007 |
J. Urol. |
pmid:17706714
|
Cunningham VJ et al. |
Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium. |
1996 |
J. Pharmacol. Exp. Ther. |
pmid:8613961
|
Hotta N et al. |
Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. |
1996 |
J. Pharmacol. Exp. Ther. |
pmid:8558455
|